Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4
about
sameAs
The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) familyStructure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpuraBinding of ADAMTS13 to von Willebrand factorNegative effects of ADAMTS-7 and ADAMTS-12 on endplate cartilage differentiationCatalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulinADAMTS-12 associates with and degrades cartilage oligomeric matrix proteinCharacterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1Versican degradation and vascular diseaseAggrecanases and cartilage matrix degradationPathophysiological Function of ADAMTS Enzymes on Molecular Mechanism of Alzheimer's DiseaseThe metalloproteinase ADAMTS1: a comprehensive review of its role in tumorigenic and metastatic pathways.Versican and the regulation of cell phenotype in diseaseProcessing and localization of ADAMTS-1 and proteolytic cleavage of versican during cumulus matrix expansion and ovulationEndothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndromeDiscovery and characterization of a novel, widely expressed metalloprotease, ADAMTS10, and its proteolytic activationLeukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitorsADAMTS7B, the full-length product of the ADAMTS7 gene, is a chondroitin sulfate proteoglycan containing a mucin domainADAMTS5 Is a Critical Regulator of Virus-Specific T Cell ImmunityVersican G3 domain regulates neurite growth and synaptic transmission of hippocampal neurons by activation of epidermal growth factor receptorFibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1The secreted metalloprotease ADAMTS20 is required for melanoblast survivalAdamts-1 is essential for the development and function of the urogenital systemIdentification and characterization of ADAMTS-20 defines a novel subfamily of metalloproteinases-disintegrins with multiple thrombospondin-1 repeats and a unique GON domainBiosynthesis and expression of a disintegrin-like and metalloproteinase domain with thrombospondin-1 repeats-15: a novel versican-cleaving proteoglycanaseBreast cancer cells induce stromal fibroblasts to secrete ADAMTS1 for cancer invasion through an epigenetic changeThe ADAMTS metalloproteinasesPathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids.Age-related changes in the proteoglycans of human skin. Specific cleavage of decorin to yield a major catabolic fragment in adult skin.ADAMTS1 interacts with, cleaves, and modifies the extracellular location of the matrix inhibitor tissue factor pathway inhibitor-2.Identification of an ADAMTS-4 cleavage motif using phage display leads to the development of fluorogenic peptide substrates and reveals matrilin-3 as a novel substrate.The cleavage of semaphorin 3C induced by ADAMTS1 promotes cell migrationVersican and the control of inflammation.Synthesis and organization of hyaluronan and versican by embryonic stem cells undergoing embryoid body differentiation.Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines.The expression of a disintegrin and metalloproteinase with thrombospondin motifs 4 in human macrophages is inhibited by the anti-atherogenic cytokine transforming growth factor-β and requires Smads, p38 mitogen-activated protein kinase and c-JunThe multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis.Isolation and purification of versican and analysis of versican proteolysis.Relevance of IGFBP2 proteolysis in glioma and contribution of the extracellular protease ADAMTS1Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation.
P2860
Q21146633-4F098B68-CB51-4F2E-8A0E-694CD4FF6910Q24291691-53EAE2C5-1D45-47EE-ABEF-76C73CF35BE0Q24299876-CAFF24B8-316F-4CBF-B2D8-F5FB8B784BD1Q24302021-8A2C4ED7-954C-4808-9722-03F597277ED7Q24303614-E135BC79-210B-41BE-9D88-BA7A66F590C3Q24313406-0358C1AD-58BE-4E3F-BE1C-AA46717C5AC8Q24317122-B2FB7FD9-5866-4E57-8A23-079686C26649Q24338314-94D070BC-4459-48E1-869A-58BC1F9D8BA6Q24600539-1DB78B50-0BA7-4C67-9836-25A8E23C4357Q24804310-785101D4-30BA-4FBB-B4D5-56668A885BDEQ26738884-3E873C56-D727-404A-9FBD-2B6F8991AB4BQ27687896-24410ABC-6994-4AB4-8440-D19A4303C5B4Q27690926-F84892A0-8367-41EA-99C4-9E0C65EC51ECQ28156198-21DB8DBB-88F8-4843-ABF6-690F69DC1C92Q28277874-AD29D03B-CA12-41D9-B459-696464252E3CQ28280996-984929D0-AD52-47DE-9654-33ED2B4F8C22Q28511924-CF19039B-7728-4350-AECD-DDACAB71E532Q28512997-6134777C-BF34-4144-976B-722460E7873AQ28553566-ED31BCC5-286C-42CC-BBA5-25EC772E4F8FQ28581556-C287B827-589C-4ABA-878A-CA5BD2E75BADQ28586832-3E4EC894-A200-4529-81F3-2C6339791C96Q28587055-9CFFAFEB-A3F5-40B0-B3D9-70C8DE4046E3Q28588557-520B5CEA-2FBD-4702-A601-5951AF5D421FQ28591587-1D3BCA86-E486-46D5-BC76-FF898C5B5A6BQ28594757-DB97F1F4-1AB6-4920-BCB7-83243BA7DE96Q28730586-94A5D05E-E117-4242-A11C-EFE3AC779F8DQ29544428-9DE29E96-7BB2-40F5-956D-74D9D6ED0076Q30836366-E58C3A3B-FA0B-48A4-919E-F48C22D337C1Q31134336-EDD50F4F-D73C-4281-9500-5F9F04661B13Q33241217-AE514F4E-8C01-4327-B4ED-C1FEDAA656AFQ33274790-0DD19612-D5C6-4D74-9431-57DC1BBF1B64Q33593917-0ED928C1-9329-43D9-96CB-5ED005740F9CQ33690423-9042B5E4-F056-4116-855C-4776370ACA83Q33742788-F643FF54-8B69-45B7-BE15-AB1B590DD6CFQ33781661-AA069F63-375E-4930-B8C7-3313E553880BQ33824589-D7E94898-55DC-4143-BDCE-07C3809BDEDFQ33925634-2F07E90F-E7CF-4698-A6C5-622AE824A8DEQ33925643-F0EDE175-03EF-4B15-81F1-1E1121C69ACDQ34100940-961759FC-5E2E-4AC3-8F0E-422AD36CAD5BQ34109859-0F2CAA80-9B82-4FE1-9FB4-23CB1ED265FB
P2860
Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Versican V1 proteolysis in hum ...... ombinant ADAMTS-1 and ADAMTS-4
@ast
Versican V1 proteolysis in hum ...... ombinant ADAMTS-1 and ADAMTS-4
@en
Versican V1 proteolysis in hum ...... ombinant ADAMTS-1 and ADAMTS-4
@nl
type
label
Versican V1 proteolysis in hum ...... ombinant ADAMTS-1 and ADAMTS-4
@ast
Versican V1 proteolysis in hum ...... ombinant ADAMTS-1 and ADAMTS-4
@en
Versican V1 proteolysis in hum ...... ombinant ADAMTS-1 and ADAMTS-4
@nl
prefLabel
Versican V1 proteolysis in hum ...... ombinant ADAMTS-1 and ADAMTS-4
@ast
Versican V1 proteolysis in hum ...... ombinant ADAMTS-1 and ADAMTS-4
@en
Versican V1 proteolysis in hum ...... ombinant ADAMTS-1 and ADAMTS-4
@nl
P2093
P2860
P921
P3181
P356
P1476
Versican V1 proteolysis in hum ...... ombinant ADAMTS-1 and ADAMTS-4
@en
P2093
A W Clowes
C Verscharen
D R Zimmermann
J M Lemire
J W Fischer
J Westling
M L Iruela-Arispe
P2860
P304
13372-13378
P3181
P356
10.1074/JBC.M009737200
P407
P577
2001-01-26T00:00:00Z